These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 35592330)

  • 61. The mRNA Revolution is Coming.
    Bates M
    IEEE Pulse; 2021; 12(6):2-5. PubMed ID: 34968173
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARSCoV- 2 Infection.
    Costanzo M; De Giglio MAR; Roviello GN
    Curr Med Chem; 2022; 29(1):4-18. PubMed ID: 34355678
    [TBL] [Abstract][Full Text] [Related]  

  • 63. mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2.
    Jin Y; Hou C; Li Y; Zheng K; Wang C
    Front Immunol; 2021; 12():821538. PubMed ID: 35126377
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMINARTY vaccine (Pfizer/BioNTech).
    Andries J; Viranaicken W; Cordonin C; Herrscher C; Planesse C; Roquebert B; Lagrange-Xelot M; El-Kalamouni C; Meilhac O; Mavingui P; Couret D; Gadea G; Despres P
    Sci Rep; 2022 Apr; 12(1):5999. PubMed ID: 35397679
    [TBL] [Abstract][Full Text] [Related]  

  • 65. mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy.
    Deng Z; Tian Y; Song J; An G; Yang P
    Front Immunol; 2022; 13():887125. PubMed ID: 35720301
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2.
    Huang Q; Ji K; Tian S; Wang F; Huang B; Tong Z; Tan S; Hao J; Wang Q; Tan W; Gao GF; Yan J
    Nat Commun; 2021 Feb; 12(1):776. PubMed ID: 33536425
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Recent Advances in the Molecular Design and Delivery Technology of mRNA for Vaccination Against Infectious Diseases.
    Yang L; Tang L; Zhang M; Liu C
    Front Immunol; 2022; 13():896958. PubMed ID: 35928814
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Modified mRNA-Based Vaccines Against Coronavirus Disease 2019.
    Wang AYL
    Cell Transplant; 2022; 31():9636897221090259. PubMed ID: 35438579
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination.
    Jalkanen P; Kolehmainen P; Haveri A; Huttunen M; Laine L; Österlund P; Tähtinen PA; Ivaska L; Maljanen S; Reinholm A; Belik M; Smura T; Häkkinen HK; Ortamo E; Kantele A; Julkunen I; Lempainen J; Kakkola L
    Microbiol Spectr; 2022 Apr; 10(2):e0225221. PubMed ID: 35262410
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Advances in the design and development of SARS-CoV-2 vaccines.
    Peng XL; Cheng JS; Gong HL; Yuan MD; Zhao XH; Li Z; Wei DX
    Mil Med Res; 2021 Dec; 8(1):67. PubMed ID: 34911569
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients.
    Baron F; Canti L; Ariën KK; Kemlin D; Desombere I; Gerbaux M; Pannus P; Beguin Y; Marchant A; Humblet-Baron S
    Front Immunol; 2022; 13():827242. PubMed ID: 35309332
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A systematic and thematic analysis of the top 100 cited articles on mRNA vaccine indexed in Scopus database.
    Musa HH; Musa TH
    Hum Vaccin Immunother; 2022 Nov; 18(6):2135927. PubMed ID: 36328513
    [TBL] [Abstract][Full Text] [Related]  

  • 73. mRNA Vaccines in the COVID-19 Pandemic and Beyond.
    Hogan MJ; Pardi N
    Annu Rev Med; 2022 Jan; 73():17-39. PubMed ID: 34669432
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines.
    Szebeni J; Storm G; Ljubimova JY; Castells M; Phillips EJ; Turjeman K; Barenholz Y; Crommelin DJA; Dobrovolskaia MA
    Nat Nanotechnol; 2022 Apr; 17(4):337-346. PubMed ID: 35393599
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prior SARS-CoV-2 infection increases reactogenicity after SARS-COV-2 mRNA vaccine and could delay the administration of the vaccine based on timing of infection.
    Stellini R; Gianello R; Meloni A; Croce E; Materzanini P; Gomarasca W
    Infection; 2022 Jun; 50(3):791-793. PubMed ID: 34855188
    [No Abstract]   [Full Text] [Related]  

  • 76. COVID-19 mRNA vaccines (Pfizer-BioNTech and Moderna) in patients with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society.
    Nojszewska M; Kalinowska A; Adamczyk-Sowa M; Kułakowska A; Bartosik-Psujek H
    Neurol Neurochir Pol; 2021; 55(1):8-11. PubMed ID: 33555604
    [TBL] [Abstract][Full Text] [Related]  

  • 77. From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape.
    Chakraborty C; Sharma AR; Bhattacharya M; Lee SS
    Front Immunol; 2021; 12():679344. PubMed ID: 34305909
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Autoimmune Hepatitis Following Vaccination for SARS-CoV-2 in Korea: Coincidence or Autoimmunity?
    Kang SH; Kim MY; Cho MY; Baik SK
    J Korean Med Sci; 2022 Apr; 37(15):e116. PubMed ID: 35437965
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection.
    Kang CK; Shin HM; Choe PG; Park J; Hong J; Seo JS; Lee YH; Chang E; Kim NJ; Kim M; Kim YW; Kim HR; Lee CH; Seo JY; Park WB; Oh MD
    BMC Med; 2022 May; 20(1):181. PubMed ID: 35508998
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysis.
    Yau K; Chan CT; Abe KT; Jiang Y; Atiquzzaman M; Mullin SI; Shadowitz E; Liu L; Kostadinovic E; Sukovic T; Gonzalez A; McGrath-Chong ME; Oliver MJ; Perl J; Leis JA; Bolotin S; Tran V; Levin A; Blake PG; Colwill K; Gingras AC; Hladunewich MA
    CMAJ; 2022 Feb; 194(8):E297-E305. PubMed ID: 35115375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.